Thrombophlebitis migrans
Methodology & AI Transparency ⓘ
Thrombophlebitis migrans Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Clinical coding for Thrombophlebitis migrans uses ICD-10 I82.1 across Blood Pressure specialty care.
- 3 Typical cash cost range: Primary evaluation for Thrombophlebitis migrans incorporates 24-hour ambulatory blood in Thrombophlebitis migrans (I82.1: pressure monitoring) and symptom diary review.
- 4 Top reported side effects / signs: Key Blood Pressure biomarkers for Thrombophlebitis migrans (I82.1): Urine Albumin-to-Creatinine Ratio [Thrombophlebitis migrans I82.1] & Home Seated Blood in Thrombophlebitis migrans (I82.1: Pressure) (< 120/75 mmHg (I82.1)).
Ask our AI Specialists anything about Thrombophlebitis migrans
What Is Thrombophlebitis migrans?
Recognized across U.S. clinical coding as I82.1 (Blood Pressure), Thrombophlebitis migrans is evaluated via 24-hour ambulatory blood in Thrombophlebitis migrans (I82.1: pressure monitoring) to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Thrombophlebitis migrans (I82.1, Blood Pressure) reflects arterial smooth-muscle hypertrophy [Thrombophlebitis migrans I82.1]. longitudinal control is benchmarked via Urine Albumin-to-Creatinine Ratio [Thrombophlebitis migrans I82.1].
Common Symptoms & Clinical Signs
- • Presentation of Thrombophlebitis migrans (I82.1): calf cramping or in Thrombophlebitis migrans (I82.1: claudication triggered by)
- • Secondary Thrombophlebitis migrans clinical sign: localized extremity swelling, in Thrombophlebitis migrans (I82.1: warmth, or venous)
- • Symptom flares in Thrombophlebitis migrans correlating with Urine Albumin-to-Creatinine Ratio [Thrombophlebitis migrans I82.1] deviation outside < 15 mg/g (I82.1)
- • Functional blood pressure impact requiring 24-hour ambulatory blood in Thrombophlebitis migrans (I82.1: pressure monitoring) evaluation (I82.1)
Thrombophlebitis migrans Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I82.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Thrombophlebitis migrans I82.1] | < 15 mg/g (I82.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Thrombophlebitis migrans (I82.1: Pressure) | < 120/75 mmHg (I82.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Thrombophlebitis migrans I82.1] | 1.00 – 1.30 (I82.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Thrombophlebitis migrans
Treatment selection for Thrombophlebitis migrans depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Thrombophlebitis migrans)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network: What a 137,940-Participant Study Found Rosuvastatin is significantly reduces the risk of VTE when compared with a placebo, other statin subtypes, and fibrate. Balkan medical journal • 2023-09-11 • Meta-Analysis | N = 137,940 | 99/100 | PMID 37519020 ↗ |
| New Insights on Randomized controlled trials comparing telmisartan with losartan in the treatment: What a 1,832-Participant Study Found In comparison with losartan, telmisartan provides superior control of BP and has no association with increased risk of side effects. American journal of hypertension • 2008-05-15 • Meta-Analysis | N = 1,832 | 94/100 | PMID 18437146 ↗ |
| Can This Approach Help? Inside the Latest Research on [Effect of telmisartan on the psychological state and quality of life in stable Both drugs also improved the quality of life: enalapril influenced predominantly the psychological. Eksperimental'naia i klinicheskaia farmakologiia • 2004-01-15 • Randomized Controlled Trial | N = 30 | 82/100 | PMID 15707013 ↗ |
| Can This Approach Help? Inside the Latest Research on Single-drug treatment and combination therapy on blood pressure control and Diastolic function improved significantly in group L (P<.05). Journal of clinical hypertension (Greenwich, Conn.) • 2006-09-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 16957425 ↗ |
| Can This Approach Help? Inside the Latest Research on Additive blood-pressure-lowering and antihypertrophic effects of long-acting Ca Metabolic parameters, liver function, and kidney function did not change significantly. International heart journal • 2009-09-15 • Randomized Controlled Trial | N = 15 | 82/100 | PMID 19809205 ↗ |
Thrombophlebitis migrans Patient Community & “People Like Me” Threads
Filter Thrombophlebitis migrans community threads and patient logs by age, biological sex, dosage, and treatment duration.